Kessler, A.F.; Feldheim, J.; Schmitt, D.; Feldheim, J.J.; Monoranu, C.M.; Ernestus, R.-I.; Löhr, M.; Hagemann, C.
Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients. Biomedicines 2020, 8, 192.
https://doi.org/10.3390/biomedicines8070192
AMA Style
Kessler AF, Feldheim J, Schmitt D, Feldheim JJ, Monoranu CM, Ernestus R-I, Löhr M, Hagemann C.
Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients. Biomedicines. 2020; 8(7):192.
https://doi.org/10.3390/biomedicines8070192
Chicago/Turabian Style
Kessler, Almuth F., Jonas Feldheim, Dominik Schmitt, Julia J. Feldheim, Camelia M. Monoranu, Ralf-Ingo Ernestus, Mario Löhr, and Carsten Hagemann.
2020. "Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients" Biomedicines 8, no. 7: 192.
https://doi.org/10.3390/biomedicines8070192
APA Style
Kessler, A. F., Feldheim, J., Schmitt, D., Feldheim, J. J., Monoranu, C. M., Ernestus, R.-I., Löhr, M., & Hagemann, C.
(2020). Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients. Biomedicines, 8(7), 192.
https://doi.org/10.3390/biomedicines8070192